Jay Johnson is a Senior Scientist at the Orentreich Foundation for the Advancement of Science. Johnson earned his doctorate in Molecular Biology from Case Western Reserve University, where his thesis work focused on the molecular mechanisms underlying cell division in prokaryotes. Johnson then joined the lab of aging at the University of Pennsylvania. There, his early published work explored cellular defects in patients with Werner’s and Bloom’s syndromes, genetic diseases characterized by accelerated aging and cancer predisposition. The ultimate aim of his studies is to develop pharmacological interventions that phenocopy methionine restriction and improve human health span.